SABRA HEALTH CARE REIT, INC. (SBRA)

20.78USD -0.72% (-0.15)

Over 1M: +0.3%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

19.5 20 20.5 21
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '23 — Net Income: -15.1M Q4 '23 — Net Income: 17.2M Q1 '24 — Net Income: 26.3M Q2 '24 — Net Income: 24M Q3 '24 — Net Income: 29.8M Q4 '24 — Net Income: 46.7M Q1 '25 — Net Income: 40.3M Q2 '25 — Net Income: 65.5M Q3 '25 — Net Income: 22.5M Q4 '25 — Net Income: 27.2M Q1 '26 — Net Income: 40.9M Q2 '26 — Net Income: -25.2M -20M 0 20M 40M 60M 80M
Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Operating Income Free Cash Flow Net Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

9.9
OE margin 41.7%
Accruals -5.6%
FCF margin 43.2%
OCF margin 43.2%
ROA 1.2%
ROE 2.4%
Capex / sales —
EBITDA margin —
Gross margin —
OCF / EBIT —
Oper. margin —
ROCE —
ROIC —

2 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

7.7
EV/OE 21.5×
Div. yield 5.6%
FCF yield 7.0%
P/B 1.9×
P/C 22.9×
EV/Sales 9.0×
P/E 81.1×
EV/EBIT —
EV/GP —
Fwd P/E —
PEG —

1 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.6
RPO / sales —
RPO growth —
Segment HHI —

2 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

2.0
ND/EBITDA -0.31
F-score 6.4 pts
Cash / Debt 0.088×
Debt / Eq 0.95×
Debt payback 6.4 yr
Net debt / Eq 0.87×
Payout 455.5%
Cash runway —
Current ratio —
Interest cover —
Quick ratio —

1 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

2.5
Sales/sh Y/Y +13.2%
Sales Q/Q +24.7%
Div. growth +3.3%
EPS Y/Y -65.3%
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS next Y —

2 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.